NeuRA Magazine #20

WHAT’S IN THIS ISSUE?

This issue offers an amazing amount of hope to those affected by Alzheimer’s disease or Parkinson’s disease. We meet three researchers – brothers Dr Arne Ittner and Prof Lars Ittner, and Dr Nic Dzamko – whose work presents us with new information about the early stages of both diseases. Crucially these new realisations have the potential to reveal how we might better treat them. It’s early days yet, but these research paths hold incredible promise. This issue also looks at the benefits that are gained when people who have had a stroke use a Wii-based rehabilitation therapy, and we touch base with some of our young researchers working in the areas of back pain and injury prevention in children.

 

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.  
APPEAL